Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

KSHV Infection in Blood Donors From Texas

This study has been completed.
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio Identifier:
First received: September 28, 2000
Last updated: March 8, 2016
Last verified: March 2016
To determine the seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8) in blood donors from Texas. Also to examine the donors' demographic characteristics and to characterize the KSHV using polymerase chain reaction.

Blood Donors
Acquired Immunodeficiency Syndrome
Blood Transfusion
Herpesvirus, Kaposi Sarcoma-Associated
Sarcoma, Kaposi
HIV Infections

Study Type: Observational
Official Title: KSHV Seroprevalence in Hospital Patients From San Antonio

Resource links provided by NLM:

Further study details as provided by The University of Texas Health Science Center at San Antonio:

Study Start Date: April 1999
Estimated Study Completion Date: March 2004
  Show Detailed Description


Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00006310

Sponsors and Collaborators
The University of Texas Health Science Center at San Antonio
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Shou-Jiang Gao, PhD University of Texas
  More Information


Responsible Party: The University of Texas Health Science Center at San Antonio Identifier: NCT00006310     History of Changes
Other Study ID Numbers: 918  R01HL060604 
Study First Received: September 28, 2000
Last Updated: March 8, 2016
Health Authority: United States: Institutional Review Board
Individual Participant Data  
Plan to Share IPD: No

Additional relevant MeSH terms:
HIV Infections
Immunologic Deficiency Syndromes
Acquired Immunodeficiency Syndrome
Sarcoma, Kaposi
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immune System Diseases
Neoplasms, Connective and Soft Tissue
Neoplasms by Histologic Type
Slow Virus Diseases
Herpesviridae Infections
DNA Virus Infections
Neoplasms, Vascular Tissue processed this record on October 21, 2016